Dutasteride and Tamoxifen Interaction
Dutasteride and Tamoxifen have a potentially harmful interaction with 75% confidence. Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.
Compound Profiles
Dutasteride
Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH
Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.
View full profileTamoxifen
Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment
Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Dutasteride with Tamoxifen?
Combining Dutasteride with Tamoxifen is not recommended. Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Is Dutasteride and Tamoxifen safe together?
This combination carries significant risk. Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.
What are the interactions between Dutasteride and Tamoxifen?
Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.
How should I time Dutasteride and Tamoxifen?
Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months) and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.